Retrospective analysis of possible drug interactions in prescriptions written by branch and emergency physicians

Yıl 2020, Cilt: 2 Sayı: 3, 53 - 56, 05.12.2020

Kasım Turgut Ali Gür Abdullah Keyfo Kama Mehmet Gökhan Turtay Hakan Oğuztürk

Öz

Objectives: Drug-drug interactions may occur when more than one drug is taken by the same patient. These interactions can result in increasing, decreasing or preventing the effectiveness of drugs. In this study, prescriptions given by branch and emergency physicians were examined in terms of possible drug interactions.
Material and Methods: Patients over 65 years of age who received a prescription from both the emergency department and the internal medicine or cardiology outpatient clinic were screened over a period of six months from July to December 2019. For the selected patients, information on the name and number of drugs prescribed, age, and gender were recorded. Then, the interactions between the drugs included in the prescriptions were investigated using Drug Interaction Checker-Medscape software.
Results: The study included 93 patients (57% females), with a mean age of 73.5 years. A total of eleven serious interactions, with the highest number belonging to the interaction of aspirin-ramipril were observed in the prescriptions given by branch physicians. Comparing the prescriptions of the branch and emergency physicians, 33 serious interactions, mostly that of ibuprofen-aspirin, were detected. Among the prescriptions of branch physicians, the majority of interactions were observed between aspirin and B blockers. For the emergency physicians, the highest number of interactions were seen in NSAID-NSAIDs. In the comparison of the prescriptions of the branch and emergency physicians, the highest number of interactions was 28, observed between NSAID and beta-blockers.
Conclusion: Emergency physicians should take a detailed history of elderly patients, especially concerning their regularly renewed prescriptions when prescribing NSAID-group drugs.

Anahtar Kelimeler

Drug interaction, emergency, aspirin, NSAIDs

Kaynakça

• Referans1. Yıldırım AB, Kılınç AY. Yaşlıhastalarda polifarmasi ve ilaç etkileşimi [Polypharmacy and drug interactions in elderly patients]. Turk Kardiyol Dern Ars. 2017;45(Suppl 5):17‐21. doi:10.5543/tkda.2017.92770
• Referans2. Jetha S. Polypharmacy, the Elderly, and Deprescribing. Consult Pharm. 2015;30(9):527‐532. doi:10.4140/TCP.n.2015.527
• REferans3. Farooqui R, Hoor T, Karim N, Muneer M. Potential Drug-Drug Interactions among Patients prescriptions collected from Medicine Out-patient Setting. Pak J Med Sci. 2018;34(1):144‐148. doi:10.12669/pjms.341.13986
• Referans4. Bucşa C, Farcaş A, Cazacu I, Leucuta D, Achimas-Cadariu A, Mogosan C, et al. M. How many potential drug-drug interactions cause adverse drug reactions in hospitalized patients?. Eur J Intern Med. 2013;24(1):27‐33. doi:10.1016/j.ejim.2012.09.011
• Referans5. Drug Interactions Checker, Medscape Online Resources. Available from: https://reference.medscape.com/drug-interactionchecker
• Referans6. Soherwardi S, Chogtu B, Fazal P. Surveillance of the potential Drug-Drug Interactions in the Medicine Department of a Tertiary Care Hospital. J Clin Diag Res. 2012;6(7):1258-1261.
• Referans7. van Leeuwen RW, Swart EL, Boven E, Boom FA, Schuitenmaker MG, Hugtenburg JG. Potential drug interactions in cancer therapy: a prevalence study using an advanced screening method. Ann Oncol. 2011;22(10):2334‐2341. doi:10.1093/annonc/mdq761
• Referans8. Kashyap M, D'Cruz S, Sachdev A, Tiwari P. Drug-drug interactions and their predictors: Results from Indian elderly inpatients. Pharm Pract (Granada). 2013;11(4):191‐195. doi:10.4321/s1886-36552013000400003
• Referans9. Roblek T, Vaupotic T, Mrhar A, Lainscak M. Drug-drug interaction software in clinical practice: a systematic review. Eur J Clin Pharmacol. 2015;71(2):131‐142. doi:10.1007/s00228-014-1786-7
• Refrans10. Obreli-Neto PR, Nobili A, de Oliveira Baldoni A, Guidoni CM, de Lyra Junior DP, Pilger D, et al. Adverse drug reactions caused by drug-drug interactions in elderly outpatients: a prospective cohort study. Eur J Clin Pharmacol. 2012;68(12):1667‐1676. doi:10.1007/s00228-012-1309-3